Former Pfizer pill plant available

The 230,000-square foot Ann Arbor facility closed by Pfizer in 2008, following a $250-million expansion six years earlier, is being scrutinized by owner University of Michigan. The school considers the pill-making and -packaging operation--part of a 2-million-square-foot complex--a potential magnet for public-private partnership. Article

Suggested Articles

Lonza CEO Marc Funk is leaving for "personal reasons" after less than a year in the top job. 

Drugmakers have voluntarily recalled their generic Zantac from the U.S. market after the FDA raised concerns, but it has not been without a cost.

Just weeks after selling the sterile manufacturing assets of its Kyowa operation in Japan, it has unloaded the rest of its Kyowa drugmaking operation.